IFF (NYSE:IFF) today announced that it will release its fourth quarter and full year 2024 earnings results following the market close on Tuesday, Feb. 18, 2025. The management team will host a live webcast on Wednesday, Feb. 19, 2025, at 9:00 a.m. ET to discuss results and outlook with the investor community. IFF also announced today that the Company's management will speak at the Consumer Analyst Group of New York (CAGNY) conference on Thursday, Feb. 20, 2025 at 1:00 PM ET. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay.

Formulated for waterline application, Enviva® DUO supports gut integrity and ensures uniform product delivery to flocks, without settling in lines. NEW YORK, Jan. 15, 2025 /PRNewswire/ -- IFF (NYSE:IFF) today announced the launch of Enviva® DUO, a state-of-the-art direct-fed microbial (DFM) solution for poultry production. This innovative blend of two non-spore forming bacterial strains is designed to support the growth of beneficial gut bacteria during challenging conditions and encourage a favorable nutribiotic state ─ the interaction between nutrition, microbiome, and gut and immune function ─ for optimal bird performance.

Recognized for brand leadership with its "Timing is Everything" controlled release platform for oral drug delivery. NEW YORK, Jan. 14, 2025 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions, a global leader in polymer innovations, announced today that it has won the 2024 Pharmaceutical Technology Excellence Awards' Brand Leadership category for its "Timing is Everything" campaign. The campaign features IFF's newly designed controlled release platform, which provides customers with solutions at every turn. This award recognizes "Timing is Everything" campaign for its strategic ma

New initiative leverages AI and cultural insights to create unique fragrances for Chinese consumers, enhancing brand success. PARIS, Jan. 8, 2025 /PRNewswire/ -- IFF (NYSE:IFF) today launched its China Scent Exploration Program, a comprehensive consumer learning initiative designed to create fragrances specifically for the Chinese region. This program builds on IFF's deep regional expertise, which began in 1981 when it became the first multinational fragrance company to establish operations in China. "The Chinese fragrance market represents one of our industry's most exciting opportunities," said Ana Paula Mendonça, president, Scent, IFF. "By combining artificial intelligence with deep cult

IFF (NYSE:IFF) today unveiled the next phase in the evolution of its Board of Directors, aimed at bolstering the company's long-term strategic vision and driving profitable market share growth. New Board Chair: Kevin O'Byrne—an experienced IFF board member and chair of Centrica plc—will become Board Chair at the 2025 Annual Shareholder Meeting. O'Byrne will succeed Roger W. Ferguson, Jr. who has served as Chair since 2022. Ferguson notified IFF of his intent to not stand for reelection at the 2025 Annual Shareholder Meeting after 14 years of distinguished service. Board Appointments: Cynthia Jamison, Dr. Mehmood Khan and Vincent Intrieri will join the Board of Directors effective Jan. 1

Web-based customer platform provides answers at customers' fingertips NEW YORK, Dec. 12, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions announces the launch of its new customer experience platform, AnswerCenter. This customized environment is designed to provide comprehensive support and an elevated user experience, underscoring IFF's commitment to customer-centricity and digital innovation. While personal customer relationships and connection points are imperative, the platform is another important offering, allowing customers to be in the driver's seat when they want to quickly access information. 

DeVeau has served in senior global financial leadership roles across the organization during his 15-year IFF tenure, most recently as SVP, Corporate Finance and Investor Relations IFF (NYSE:IFF) today announced that Michael DeVeau—currently Senior Vice President, Corporate Finance and Investor Relations at IFF—has been named the company's Executive Vice President and Chief Financial Officer, effective Jan. 1, 2025. DeVeau will succeed current CFO and Business Transformation Officer Glenn Richter, whose previously announced planned retirement will take effect at the end of 2024. "We could not be more pleased than naming Mike as our CFO," said Erik Fyrwald, IFF CEO. "Mike is a trusted, ex

New enzymatic solution promises premium textures in fermented dairy and plant-based products, eliminating the need for stabilizers. NEW YORK, Nov. 14, 2024 /PRNewswire/ -- IFF (NYSE:IFF) today announced the launch of TEXSTAR™, an advanced enzymatic texturizing solution poised to revolutionize the texture of both dairy and plant-based fresh fermented products. This innovative enzyme provides the necessary viscosity in fresh fermented products, without the use of added stabilizers. TEXSTAR™ will enable manufacturers to create products with unique textures that feature familiar, consumer-accepted ingredients. Additionally, the enzyme will allow supply chain fluctuations to be managed more effec

IFF (NYSE:IFF) reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.9 B   $95 M   $0.23   $568 M   19.4%   $1.04       First Nine Months 2024 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $8.7 B   $393 M  

Alexandra Carlin and Alex Lee join the Paris-based fine fragrance team, bringing fresh artistic perspectives PARIS, Nov. 4, 2024 /PRNewswire/ -- IFF (NYSE:IFF) proudly welcomes Alexandra Carlin as Senior Fine Fragrance Perfumer and Alex Lee as Fine Fragrance Perfumer to its Paris-based team. These strategic additions aim to enhance the Company's creative prowess in the world of perfumery. "We're excited for the talent and creative energy that Alexandra and Alex will bring to IFF Scent," said Sabrya Meflah, president, Fine Fragrance, IFF. "Alexandra's ability to translate deep

Argus upgraded Intl Flavors from Hold to Buy

Morgan Stanley upgraded Intl Flavors from Equal-Weight to Overweight and set a new price target of $110.00 from $111.00 previously

BofA Securities upgraded Intl Flavors from Neutral to Buy and set a new price target of $107.00

Vertical Research upgraded Intl Flavors from Hold to Buy and set a new price target of $109.00

Oppenheimer reiterated coverage of Intl Flavors with a rating of Outperform and set a new price target of $117.00 from $116.00 previously

Mizuho upgraded Intl Flavors from Neutral to Outperform and set a new price target of $120.00 from $109.00 previously

Stifel upgraded Intl Flavors from Hold to Buy and set a new price target of $115.00 from $95.00 previously

Oppenheimer initiated coverage of Intl Flavors with a rating of Outperform and set a new price target of $116.00

Morgan Stanley downgraded Intl Flavors from Overweight to Equal-Weight and set a new price target of $100.00

JP Morgan upgraded Intl Flavors from Neutral to Overweight and set a new price target of $100.00 from $75.00 previously

8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

144 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

10-Q - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

10-Q - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

11-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

IFF (NYSE:IFF) today announced that it will release its fourth quarter and full year 2024 earnings results following the market close on Tuesday, Feb. 18, 2025. The management team will host a live webcast on Wednesday, Feb. 19, 2025, at 9:00 a.m. ET to discuss results and outlook with the investor community. IFF also announced today that the Company's management will speak at the Consumer Analyst Group of New York (CAGNY) conference on Thursday, Feb. 20, 2025 at 1:00 PM ET. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay.

IFF (NYSE:IFF) reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.9 B   $95 M   $0.23   $568 M   19.4%   $1.04       First Nine Months 2024 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $8.7 B   $393 M  

IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on January 8, 2025 to shareholders of record as of December 20, 2024. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we

IFF (NYSE:IFF) today announced that it will release its third quarter 2024 earnings results following the market close on Tuesday, Nov. 5, 2024. The management team will host a live webcast on Wednesday, Nov. 6, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from g

IFF (NYSE:IFF) reported financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.9 B   $183 M   $0.66   $588 M   20.4%   $1.16 First Six Months 2024 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating E

IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 9, 2024 to shareholders of record as of September 20, 2024. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we

IFF (NYSE:IFF) today announced that it will release its second quarter 2024 earnings results following the market close on Tuesday, August 6, 2024. The management team will host a live webcast on Wednesday, August 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world

IFF (NYSE:IFF) reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.9 B   $115 M   $0.23   $578 M   19.9%   $1.13 Management Commentary "We have started the year well, with good results across the majority of our business," said IFF CEO Erik Fyrwald. "In the first quarter, we delivered volume growth and productivity gains, which res

IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 10, 2024 to shareholders of record as of June 21, 2024. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will d

IFF (NYSE:IFF) today announced that it will release its first quarter 2024 earnings results following the market close on Monday, May 6, 2024. The management team will host a live webcast on Tuesday, May 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from glob

SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

SC 13G - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

SC 13D/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

Alexandra Carlin and Alex Lee join the Paris-based fine fragrance team, bringing fresh artistic perspectives PARIS, Nov. 4, 2024 /PRNewswire/ -- IFF (NYSE:IFF) proudly welcomes Alexandra Carlin as Senior Fine Fragrance Perfumer and Alex Lee as Fine Fragrance Perfumer to its Paris-based team. These strategic additions aim to enhance the Company's creative prowess in the world of perfumery. "We're excited for the talent and creative energy that Alexandra and Alex will bring to IFF Scent," said Sabrya Meflah, president, Fine Fragrance, IFF. "Alexandra's ability to translate deep

NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite excipients and ultrapure alginate biopolymers for next-generation therapeutic development. "We are unveiling groundbreaking technologies that re

IFF (NYSE:IFF) today announced the appointment of Margarita Paláu-Hernández to its Board of Directors, effective June 3, 2024. Paláu-Hernández joins as a mutually agreed independent Director in connection with IFF's previously disclosed cooperation agreement with Icahn Capital LP and its affiliates. Following the appointment of Paláu-Hernández, the Board will be comprised of 11 members, ten of which are independent. "We are pleased to welcome Maggie to the IFF Board," said Roger Ferguson, lead director of IFF. "Her legal expertise, consumer insights, and her experience in emerging markets will be invaluable to IFF as we continue to execute on our growth and transformation plan to drive in

International Flavors & Fragrances Inc. (NYSE:IFF) reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.7 B   $(2.6) B   $(10.21)   $461 M   17.1%   $0.72 Full Year 2023 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes   EPS

NEW YORK, Feb. 15, 2024 /PRNewswire/ -- IFF today announced the promotion of three perfumers to vice president perfumers: Patricia "Patty" Hidalgo, Joa Kim and Birgit Sijbrands. Patricia "Patty" Hidalgo — a beacon of creativity and innovation in the fragrance industry with a storied career spanning three decades — began her journey at IFF by joining through the Fragrance Resources acquisition in 2017. A scholar in biology and chemistry, her technical skills propelled her from a laboratory technician to a towering strength in perfumery creation, where she has since been craftin

IFF (NYSE:IFF) today announced the appointment of J. Erik Fyrwald to succeed Frank Clyburn as Chief Executive Officer and member of the IFF Board of Directors, effective Feb. 6, 2024. Clyburn will work closely with Fyrwald to ensure a seamless transition, remaining with IFF until March 31, 2024, and further serving in an advisory capacity through December 2024. Fyrwald brings to IFF more than four decades of executive and operational experience driving innovation and profitable, sustainable growth at leading corporations in the nutrition, agriculture and chemicals industries. He most recently served as Chief Executive Officer of Syngenta, where he spearheaded the strategy that ultimately

International Flavors & Fragrances Inc. (NYSE:IFF) reported financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.8 B   $(5) M   $0.01   $441 M   15.5%   $0.97 Full Year 2022 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Loss Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $12.4 B   $(1.

IFF (NYSE:IFF) today announced the appointment of Gary Hu to the Company's Board of Directors, effective Feb. 1, 2023. Hu, a portfolio manager at Icahn Capital, will be appointed to the Board's Audit and Transaction Committees. In connection with this appointment, IFF has entered into a cooperation agreement with Icahn Capital LP and its affiliates. "On behalf of the IFF Board of Directors, I would like to welcome Gary to the Board," said Dale Morrison, chairman of IFF's Board of Directors. "We expect that Gary's board experience – coupled with his financial and investment expertise – will prove a solid addition to our Board. We look forward to working alongside him as we continue to execu

IFF (NYSE:IFF) today announced the appointment of accomplished consumer products industry executive Dawn Willoughby to the Company's Board of Directors as an independent director, effective Feb. 1, 2023. Willoughby, who most recently served as executive vice president and chief operating officer of The Clorox Company, brings an impressive track record of driving sustainable, profitable growth with a focus on innovation and sustainability for global consumer businesses. "We are thrilled to welcome Dawn to the IFF Board as we continue to evolve our Board consistent with the plans announced in our December Investor Day, and prioritize the addition of senior executives with the most relevant s

NEW YORK, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ:EXLS), a leading global data analytics and digital operations and solutions company, today announced that Andreas Fibig, a seasoned global executive with a strong record of innovation across industries and geographies, has been appointed to EXL's Board of Directors as an independent director effective Jan. 10, 2023. Fibig will be a member of the Board's Audit and Nominating and Governance Committees. "Andreas is a distinguished global business leader with more than 25 years of international health care, pharmaceutical, and consumer industry experience," said Vikram S. Pandit, Chairman of the Board of EXL. "We lo